Immune markers are predictive of CMV infection in seropositive lung transplant recipients

被引：0
|
作者：
Gardiner, Bradley [1 ,2 ]
Lee, Sue [1 ]
Robertson, Allisa N. [1 ]
Snell, Gregory I. [2 ,3 ]
Westall, Glen P. [2 ,3 ]
Peleg, Anton Y. [1 ,2 ]
机构：
[1] Monash Univ, Sch Translat Med, Melbourne, Vic, Australia
[2] Alfred Hlth, Dept Resp Med, Lung Transplant Serv, Melbourne, Vic, Australia
[3] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
222.6
引用
收藏
页码：40 / 40
页数：1
相关论文
共 50 条
  • [31] CYTOKINE AND CHEMOKINE GENE POLYMORPHISMS IMPACT ON CMV INFECTION IN LUNG TRANSPLANT RECIPIENTS
    Zeevi, Adriana
    Hong, Nguyen
    Brooks, Maria
    Spichty, Kathy
    Zaldonis, Diana
    Ferrell, Robert
    Silveira, Fernanda
    Pilewski, Joseph
    Crespo, Maria
    Bhama, Jay
    Bermudez, Christian
    Clancy, Cornelius
    HUMAN IMMUNOLOGY, 2012, 73 : 32 - 32
  • [32] Cytomegalovirus infection in seromismatched lung transplant recipients with and without prophylaxis with CMV immunoglobulin
    Kathawalla, SA
    Stillwell, PC
    Gordon, S
    Haug, M
    Perl, M
    Arroliga, AC
    Mehta, AC
    Avery, R
    Kirby, T
    TRANSPLANTATION PROCEEDINGS, 1996, 28 (06) : 16 - 16
  • [33] Donor CMV Reactivation as a Novel Risk Factor for CMV Replication in Seropositive Liver Transplant Recipients
    Limaye, Ajit P.
    Rahnemai-Azar, Amir A.
    Nazarian, Susanna M.
    Perkins, James D.
    Reyes, Jorge D.
    TRANSPLANTATION DIRECT, 2021, 7 (01): : E637
  • [34] Single Center Experience of Valganciclovir and Adjunctive CMV IVIG for the Treatment of CMV Infection in Lung Transplant Recipients
    Fernandez, A. A.
    Sinha, N.
    Loebe, M.
    Glaze, J.
    Manickavel, S.
    Fernandez, M.
    Pastrana, T.
    Simkins, J.
    Camargo, J.
    Morris, M. I.
    Abbo, L.
    Natori, Y.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 800 - 800
  • [35] CMV INFECTION IN HEART-TRANSPLANT RECIPIENTS
    THOMPSON, KS
    PLAPP, FV
    LONG, ND
    HEENAN, TA
    TRANSFUSION, 1992, 32 (08) : S65 - S65
  • [36] Discordance Between Humoral and Cellular Immune Responses to Cytomegalovirus Infection in CMV Seropositive Recipients (R plus )
    Boada Perez, M.
    Berastegui Garcia, C.
    Erro, M.
    Ussetti, P.
    Crespo, E.
    Donadeu, L.
    Bestard, O.
    Anguera, G.
    Sole, A.
    Ponz, R.
    Molloy, B.
    Revilla, E.
    Monforte, V.
    Gomez, S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S109 - S110
  • [37] A Single Center Experience of Letermovir for the Prevention of CMV Infection in CMV-Seropositive Allogeneic Cell Transplant (Allo-HCT) Recipients
    Foolad, Farnaz
    Shigle, Terri Lynn
    Handy, Victoria Wehr
    Khawaja, Fareed
    Aitken, Samuel L.
    Chemaly, Roy F.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [38] Impact of Different Prevention Strategies On the Risk of Cytomegalovirus (CMV) Infection and Disease in Seropositive Kidney Transplant (KT) Recipients
    Aguado, J.
    Fernandez-Ruiz, M.
    Arias, M.
    Campistol, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 765 - 766
  • [39] CMV infection and CMV disease in kidney transplant recipients - our experience
    Chrastina, N.
    Zilinska, Z.
    Breza, J., Jr.
    Breza, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (01): : 42 - 42
  • [40] CMV infection and CMV disease in kidney transplant recipients - our experiences
    Chrastina, M.
    Zilinska, Z.
    Breza, J.
    Breza, J., Jr.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2008, 109 (05): : 246 - 246
12345